Istiratumab

Istiratumab (M-6495) is a bispecific monoclonal antibody against IGF-1R and ErbB3 that induces degradation of IGF-1R and ErbB3 receptors through the proteasomal pathway and can be used in cancer research.
Supplier Alfa Cytology
Product # PC0126
Pricing 1 mg, 5 mg,10 mg, inquire
Feedback